Email Us

100 Loci of 18 Deafness-Related Genes Detection CapitalBio

According to WHO, over 5% of the world's population, that is, 360 million people, has disabling hearing loss. Among them, 328 million are adults and 32 million are children. WHO points out that early detection and intervention are crucial to minimizing the impact of hearing loss on individuals and screening for ear diseases and hearing loss is an effective tool for early identification and management of hearing loss. Therefore, it urges member states to develop, implement and monitor screening programs for early identification of ear diseases and hearing loss in high-risk populations.


maternal and child health care

Features of 100 Loci of 18 Deafness-Related Genes Detection

This test is based on NGS technology, it can cover GJB2, SLC26A4, GJB3, MT-RNR1, etc. 18 genes, detect up to 100 deafness mutation sites.


Clinical Applications of 100 Loci of 18 Deafness-Related Genes Detection

Auxiliary diagnosis: search for the cause of suspected hereditary deafness and assist clinical diagnosis.

Disease risk assessment: conduct risk assessment for high-risk groups with family history and provide early intervention programs to reduce the risk of disease.


Specification of 100 Loci of 18 Deafness-Related Genes Detection

Sample typeVenous Blood/ Dried Blood Spot
TAT10 days


Products
Contact with Capitalbio
Contact Information
Your Inquiries (Expandable)
Instruments
Detection Kits/Reagents
Research Services
Biochip Design & Fabrication
Diagnostic Services
86-10-69002900
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing